CIK 0001743881
- Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,117,307
- in 3 filings, $5.1M under 10b5-1 plans
Net −$5,117,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-19 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −8,500 | $78.35 | $666K | 477,186 |
| 2026-11-19 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −1,500 | $79.29 | $119K | 475,686 |
| 2026-11-18 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −4,490 | $76.99 | $346K | 273,817 |
| 2026-11-18 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −30,490 | $77.83 | $2.4M | 243,327 |
| 2026-11-18 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −1,277 | $76.99 | $98K | 494,409 |
| 2026-11-18 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −8,723 | $77.83 | $679K | 485,686 |
| 2026-11-16 | Trimarchi Thomas President and CFO | Shares withheld for taxes | −22,781 | $77.36 | $1.8M | 313,748 |
| 2026-11-16 | Apuli Maricel Chief Accounting Officer | Shares withheld for taxes | −4,714 | $77.36 | $365K | 115,973 |
| 2026-11-16 | Kumar Neil Chief Executive Officer | Exercise or conversion | +33,544 | 276,871 | ||
| 2026-11-16 | Kumar Neil Chief Executive Officer | Exercise or conversion | +19,599 | 296,470 | ||
| 2026-11-16 | Kumar Neil Chief Executive Officer | Exercise or conversion | +11,554 | 308,024 | ||
| 2026-11-16 | Kumar Neil Chief Executive Officer | Exercise or conversion | +6,519 | 314,543 | ||
| 2026-11-16 | Kumar Neil Chief Executive Officer | Shares withheld for taxes | −36,236 | $77.36 | $2.8M | 278,307 |
| 2026-11-16 | Kumar Neil Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −33,544 | 33,544 | ||
| 2026-11-16 | Kumar Neil Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −19,599 | 97,997 | ||
| 2026-11-16 | Kumar Neil Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −11,554 | 103,984 | ||
| 2026-11-16 | Kumar Neil Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −6,519 | 84,755 | ||
| 2026-10-30 | Apuli Maricel Chief Accounting Officer | Sale 10b5-1 | −2,000 | $72.85 | $146K | 120,687 |
| 2026-09-17 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −8,721 | $69.01 | $602K | 496,965 |
| 2026-09-17 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −1,279 | $69.57 | $89K | 495,686 |
Page 1 of 61 · 1,201 trades